Different Type of Antipsychotic Therapies on Length of Stay of Acute Schizophrenia Patients in Sungai Bangkong Regional Mental Hospital Pontianak

Schizophrenia is one of severe mental disorders that affects how a person thinks, feels, and acts. In 2013, the prevalence of schizophrenia in West Kalimantan was 0,7 per 1000 inhabitants. This study aimed to determine whether there was any difference in patients’ length of stay of inter-type of antipsychotic therapies given to acute phase schizophrenia patients in Sungai Bangkong Regional Mental Hospital in the period of January–December 2014. The study design was a cross-sectional analysis with retrospective data collecting method. This study was carried out to 98 patients’ medical records who received antipsychotic therapy. Data were analyzed with univariate and bivariate analysis. Univariate analysis gave an overview of patients’ characteristics while bivariate analysis was used to see whether there was any difference in patients’ length of stay of inter-type of antipsychotic therapies. The result showed that the most widely used antipsychotic and adjuvant by patients were risperidone and trihexyphenidyl as many as 446 times (25,32%) and 340 times (65,89%), respectively. Analysis result using One-Way ANOVA showed that the length of stay of acute phase schizophrenia patients, treated with typical monotherapy, atypical monotherapy, and polytherapy, had no significant difference (p>0,05). It showed that length of stay of inter-type of antipsychotic therapies were not different, thus it could be concluded that type of antipsychotic therapies didn’t affect the differences in patients’ length of stay